Qiagen introduces companion diagnostic for breast cancer - 1 views
-
jacob logan on 29 May 19Qiagen has launched the new therascreen PIK3CA RGQ PCR Kit as a companion diagnostic for the detection of patients who could benefit from treatment with Swiss pharmaceutical company Novartis' new breast cancer drug, Piqray (alpelisib).